Christopher Pierce - EVP and Chief of Business Oper at Prelude Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP and Chief of Business Oper
Stock Symbol
PRLD on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Christopher Pierce since 11/12/2023

Holdings reported by Christopher Pierce for Prelude Therapeutics Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 3.75K $14.1K $3.77 Sep 2, 2021 Direct
Employee Stock Option (right to buy) 208K Sep 2, 2021 Direct Common Stock

Transactions reported by Christopher Pierce for Prelude Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.